Amapharm
Amapharm, a prominent player in the pharmaceutical industry, is headquartered in Germany (DE) and operates extensively across Europe. Founded in 2003, the company has established itself as a leader in the development and distribution of high-quality generic medicines and active pharmaceutical ingredients (APIs). Amapharm's core offerings include a diverse range of pharmaceutical products that cater to various therapeutic areas, distinguished by their commitment to quality and regulatory compliance. The company has achieved significant milestones, including strategic partnerships and expansions that enhance its market position. With a focus on innovation and sustainability, Amapharm continues to make strides in the pharmaceutical sector, ensuring that it meets the evolving needs of healthcare providers and patients alike.
DitchCarbon Score
How does Amapharm's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Amapharm's score of 20 is lower than 60% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Amapharm's reported carbon emissions
Amapharm GmbH, headquartered in Germany, has set ambitious climate commitments despite not having specific carbon emissions data available. The company has committed to reducing its Scope 1 and Scope 2 greenhouse gas (GHG) emissions by 42% by 2030, using 2020 as the baseline year. This target has been validated through the Science Based Targets initiative (SBTi) and aligns with the necessary reductions to limit global warming to 1.5°C. Additionally, Amapharm plans to measure and address its Scope 3 emissions, demonstrating a comprehensive approach to its climate impact. As a small to medium-sized enterprise in the food and beverage processing sector, Amapharm's initiatives reflect a growing trend among SMEs to engage in meaningful climate action.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Amapharm is committed to some reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
